Anatomical and functional healing after resorbable magnesium scaffold implantation in human coronary vessels: A combined optical coherence tomography and quantitative flow ratio analysis
- 15 November 2020
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (6), 1038-1046
- https://doi.org/10.1002/ccd.29397
Abstract
Background No data are currently available on the process of vessel healing and long‐term physiological results after implantation of resorbable magnesium‐made scaffold (RMS) in human coronary arteries. Objectives To investigate after percutaneous coronary intervention (PCI) and at 12 months follow‐up (a) RMS resorption process and vessel healing, as judged by optical coherence tomography (OCT) imaging; and (b) physiological result of RMS implantation evaluated by quantitative flow ratio (QFR). Methods All patients successfully treated with at least one RMS from July 2016 to August 2018 at 2 Italian centers were evaluated. All cases with OCT pullback and/or coronary angiography suitable for QFR analysis performed after PCI and at 12 months were included. Resorption process was analyzed at OCT in each frame reporting presence of residual struts in the vessel. Results Forty‐four patients/forty‐nine lesions were included. 12‐months mean lumen area (LA; 7.54 ± 3.04 mm2) significantly decreased compared to mean LA recorded immediately after PCI (8.12 ± 1.89 mm2; p < .01). However, LA changes did not affect the functional result of PCI with a non‐ischemic QFR value (>0.80) in 98% of cases at 12‐months follow‐up. Protruding struts were detectable in more than half of cases and their presence was correlated with an increase in mean LA (+0.73mm2 [95% CI 0.51–0.94], p < .001). Conclusions RMS implantation in a real‐world population lead to significant decrease in mean LA without significant functional impairment. Two different patterns of RMS resorption were recorded, whose clinical significance remains to be investigated.This publication has 29 references indexed in Scilit:
- First reported case of magnesium‐made bioresorbable scaffold to treat spontaneous left anterior descending coronary artery dissectionCatheterization and Cardiovascular Interventions, 2017
- Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-IIIEuroIntervention, 2017
- Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery modelEuroIntervention, 2017
- Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic StentsJournal of the American College of Cardiology, 2017
- Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent ImplantationCirculation, 2017
- Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary AngiographyJACC: Cardiovascular Interventions, 2016
- Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients withde novocoronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trialEuropean Heart Journal, 2016
- Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanismsEuropean Heart Journal, 2015
- Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trialThe Lancet, 2015
- Role of Endothelial Shear Stress in Stent Restenosis and Thrombosis: Pathophysiologic Mechanisms and Implications for Clinical TranslationJournal of the American College of Cardiology, 2012